Summary:
This is a phase 3 study for patients with chronic low back pain: 5 month duration - with a 3 week open-label period, followed by a 12-week double-blind period. There are 13 office visits and 2 phone calls.
Qualified Participants Must:
• Have diagnosis of Chronic Low Back Pain
• Be 21-75 years of age
• Be taking pain medication daily for at least 3 months
•
Qualified Participants May Receive:
Study medication at no cost; doctor visits, blood work, physical, EKG; compensation for participation upon completion of study.